Hazard ratio for secondary cardiovascular outcomes associated with Lipoprotein(a) ≥ 200 vs. <200 nmol/L
Secondary outcome . | Unadjusted . | Adjusted . | ||||
---|---|---|---|---|---|---|
. | HR . | 95% CI . | P-value . | HR . | 95% CI . | P-value . |
MI | 1.41 | (1.12–1.78) | 0.004 | 1.40 | (1.11–1.78) | 0.005a |
Ischaemic stroke | 1.19 | (0.83–1.72) | 0.336 | 1.13 | (0.77–1.66) | 0.536b |
Coronary revascularization | 1.40 | (1.13–1.72) | 0.002 | 1.42 | (1.14–1.75) | 0.001a |
CHD death | 1.40 | (1.07–1.83) | 0.013 | 1.52 | (1.16–2.01) | 0.003c |
CHD death and MI | 1.31 | (1.08–1.60) | 0.007 | 1.35 | (1.10–1.66) | 0.004a |
CV death | 1.27 | (1.02–1.58) | 0.029 | 1.39 | (1.10–1.74) | 0.005a |
CV death, MI, and ischaemic stroke | 1.27 | (1.07–1.51) | 0.005 | 1.31 | (1.09–1.56) | 0.003a |
CV death, MI, ischaemic stroke, and coronary revascularization | 1.26 | (1.08–1.47) | 0.003 | 1.29 | (1.10–1.51) | 0.002a |
All-cause mortality | 1.04 | (0.89–1.22) | 0.622 | 1.10 | (0.93–1.30) | 0.255a |
Secondary outcome . | Unadjusted . | Adjusted . | ||||
---|---|---|---|---|---|---|
. | HR . | 95% CI . | P-value . | HR . | 95% CI . | P-value . |
MI | 1.41 | (1.12–1.78) | 0.004 | 1.40 | (1.11–1.78) | 0.005a |
Ischaemic stroke | 1.19 | (0.83–1.72) | 0.336 | 1.13 | (0.77–1.66) | 0.536b |
Coronary revascularization | 1.40 | (1.13–1.72) | 0.002 | 1.42 | (1.14–1.75) | 0.001a |
CHD death | 1.40 | (1.07–1.83) | 0.013 | 1.52 | (1.16–2.01) | 0.003c |
CHD death and MI | 1.31 | (1.08–1.60) | 0.007 | 1.35 | (1.10–1.66) | 0.004a |
CV death | 1.27 | (1.02–1.58) | 0.029 | 1.39 | (1.10–1.74) | 0.005a |
CV death, MI, and ischaemic stroke | 1.27 | (1.07–1.51) | 0.005 | 1.31 | (1.09–1.56) | 0.003a |
CV death, MI, ischaemic stroke, and coronary revascularization | 1.26 | (1.08–1.47) | 0.003 | 1.29 | (1.10–1.51) | 0.002a |
All-cause mortality | 1.04 | (0.89–1.22) | 0.622 | 1.10 | (0.93–1.30) | 0.255a |
Bold text indicates statistical significance at an alpha level of 0.05.
CI, confidence interval; CHD, coronary heart disease; CV, cardiovascular; HR, hazard ratio; MI, myocardial infarction.
Adjusted for: Age, sex, hypertension, hyperlipidaemia, diabetes mellitus, chronic kidney disease, and smoking.
Adjusted for: Age and sex.
Adjusted for: Age, sex, hypertension, hyperlipidaemia, diabetes mellitus, and chronic kidney disease.
Hazard ratio for secondary cardiovascular outcomes associated with Lipoprotein(a) ≥ 200 vs. <200 nmol/L
Secondary outcome . | Unadjusted . | Adjusted . | ||||
---|---|---|---|---|---|---|
. | HR . | 95% CI . | P-value . | HR . | 95% CI . | P-value . |
MI | 1.41 | (1.12–1.78) | 0.004 | 1.40 | (1.11–1.78) | 0.005a |
Ischaemic stroke | 1.19 | (0.83–1.72) | 0.336 | 1.13 | (0.77–1.66) | 0.536b |
Coronary revascularization | 1.40 | (1.13–1.72) | 0.002 | 1.42 | (1.14–1.75) | 0.001a |
CHD death | 1.40 | (1.07–1.83) | 0.013 | 1.52 | (1.16–2.01) | 0.003c |
CHD death and MI | 1.31 | (1.08–1.60) | 0.007 | 1.35 | (1.10–1.66) | 0.004a |
CV death | 1.27 | (1.02–1.58) | 0.029 | 1.39 | (1.10–1.74) | 0.005a |
CV death, MI, and ischaemic stroke | 1.27 | (1.07–1.51) | 0.005 | 1.31 | (1.09–1.56) | 0.003a |
CV death, MI, ischaemic stroke, and coronary revascularization | 1.26 | (1.08–1.47) | 0.003 | 1.29 | (1.10–1.51) | 0.002a |
All-cause mortality | 1.04 | (0.89–1.22) | 0.622 | 1.10 | (0.93–1.30) | 0.255a |
Secondary outcome . | Unadjusted . | Adjusted . | ||||
---|---|---|---|---|---|---|
. | HR . | 95% CI . | P-value . | HR . | 95% CI . | P-value . |
MI | 1.41 | (1.12–1.78) | 0.004 | 1.40 | (1.11–1.78) | 0.005a |
Ischaemic stroke | 1.19 | (0.83–1.72) | 0.336 | 1.13 | (0.77–1.66) | 0.536b |
Coronary revascularization | 1.40 | (1.13–1.72) | 0.002 | 1.42 | (1.14–1.75) | 0.001a |
CHD death | 1.40 | (1.07–1.83) | 0.013 | 1.52 | (1.16–2.01) | 0.003c |
CHD death and MI | 1.31 | (1.08–1.60) | 0.007 | 1.35 | (1.10–1.66) | 0.004a |
CV death | 1.27 | (1.02–1.58) | 0.029 | 1.39 | (1.10–1.74) | 0.005a |
CV death, MI, and ischaemic stroke | 1.27 | (1.07–1.51) | 0.005 | 1.31 | (1.09–1.56) | 0.003a |
CV death, MI, ischaemic stroke, and coronary revascularization | 1.26 | (1.08–1.47) | 0.003 | 1.29 | (1.10–1.51) | 0.002a |
All-cause mortality | 1.04 | (0.89–1.22) | 0.622 | 1.10 | (0.93–1.30) | 0.255a |
Bold text indicates statistical significance at an alpha level of 0.05.
CI, confidence interval; CHD, coronary heart disease; CV, cardiovascular; HR, hazard ratio; MI, myocardial infarction.
Adjusted for: Age, sex, hypertension, hyperlipidaemia, diabetes mellitus, chronic kidney disease, and smoking.
Adjusted for: Age and sex.
Adjusted for: Age, sex, hypertension, hyperlipidaemia, diabetes mellitus, and chronic kidney disease.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.